Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown

The best hope of controlling the herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) pandemic is the development of an effective vaccine. However, in spite of several clinical trials, starting as early as 1920s, no vaccine has been proven sufficiently safe and efficient to warrant commercial de...

Descripción completa

Detalles Bibliográficos
Autores principales: Alami Chentoufi, Aziz, Kritzer, Elizabeth, Yu, David M., Nesburn, Anthony B., BenMohamed, Lbachir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324142/
https://www.ncbi.nlm.nih.gov/pubmed/22548113
http://dx.doi.org/10.1155/2012/187585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324142/
https://www.ncbi.nlm.nih.gov/pubmed/22548113
http://dx.doi.org/10.1155/2012/187585

Ejemplares similares